GSK holds launching ceremony for Ultiva

Published: 2004-10-29 06:59:00

Updated: 2004-10-29 06:59:00

GSK said its launching ceremony for Ultiva (remifentanil hydrochloride), a new analgesic opioid agent, was held on October 23 at Grand Hyatt Hotel, where 300 local anesthetists attended.

Because of the unique pharmacology of Ultiva compared to other currently available agents, the drug can be...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK